Trials / Conditions / Lou-Gehrigs Disease
Lou-Gehrigs Disease
3 registered clinical trials studyying Lou-Gehrigs Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS NCT03520517 | Biohaven Pharmaceuticals, Inc. | Phase 1 |
| Withdrawn | Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Diso NCT01459302 | University of Massachusetts, Worcester | — |
| No Longer Available | Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS) NCT03537807 | Biohaven Pharmaceuticals, Inc. | — |